Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 18 pseudogene 12 (KRT18P12) is one of many processed pseudogenes generated from the functional keratin 18 gene (KRT18), a type I intermediate filament protein-coding gene[1][3]. While the functional KRT18 gene encodes a protein important for epithelial cell structure and is implicated as a biomarker in various cancers, its numerous pseudogenes—including KRT18P12—are considered nonfunctional genomic elements that do not code for any protein or play any direct biological role. Pseudogenes like KRT18P12 are generally widely dispersed throughout the genome and lack open reading frames, arising as byproducts of gene duplication or retrotransposition. These pseudogenes are not drug targets, do not act as receptors, and are not involved in disease pathogenesis or therapy[1][3].
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 18 pseudogene 12 (KRT18P12).